News

August 24, 2022

Anthony Fauci announced that he plans to step down as Director of the National Institute of Allergy and Infectious Diseases in December 2022.

August 24, 2022

Aerie to be purchased by Alcon after recently bringing two glaucoma drugs to market.

August 23, 2022

NICE has recommended the use of Tavneos (avacopan) in combination with rituximab or cyclophosphamide regimen.

August 23, 2022

Kapruvia (difelikefalin) has been granted approval by Swissmedic as a treatment for moderate-to-severe pruritis associated with CKD.

August 23, 2022

The European Commission (EC) has approved Celltrion Healthcare's Vegzelma (CT-P16), a biosimilar to bevacizumab referencing Avastin.

August 23, 2022

The latest CPHI report has been published, predicting that a significant shift in outsourcing strategies is being experienced globally.

August 23, 2022

EMA has accepted the marketing authorization application for an oral fixed-dose combination treatment as an initial treatment for adults with AML.

August 22, 2022

Grand River Aseptic Manufacturing has completed phase II of its facility expansion with the installation of two new sterile filling lines.

August 22, 2022

ProBioGen will collobarate with NextPoint Therapeutics to develop and manufacture its lead antibody candidate.

August 16, 2022

Validair Diamond Scientific has installed a new cleanroom for in-house testing, research, and training.